Effects of K-877, a novel selective PPARα modulator, on small intestine contribute to the amelioration of hyperlipidemia in low-density lipoprotein receptor knockout mice

Peroxisome proliferator-activated receptor α (PPARα) is a well-known therapeutic target for treating hyperlipidemia. K-877 is a novel selective PPARα modulator (SPPARMα) that enhances PPARα transcriptional activity with high selectivity and potency, resulting in reduced plasma lipid levels. This stu...

Full description

Bibliographic Details

Published in:	Journal of Pharmacological Sciences
Main Authors:	Kenta Takei, Yoshimi Nakagawa, Yunong Wang, Song-iee Han, Aoi Satoh, Motohiro Sekiya, Takashi Matsuzaka, Hitoshi Shimano
Format:	Article
Language:	English
Published:	Elsevier 2017-04-01
Subjects:	PPARα SPPARMα HDL cholesterol Cholesterol absorption
Online Access:	http://www.sciencedirect.com/science/article/pii/S134786131730018X